Russell Investments »

Inhibrx Biosciences shares owned by Russell Investments

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $1000k 71k 14.17

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Eli Lilly And Company Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Welltower Common Stock (WELL)
Prologis Common Stock (PLD)
Digital Realty Trust Common Stock (DLR)
J P Morgan Chase And Common Stock (JPM)

View all positions for Russell Investments

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Geode Capital Management
Morgan Stanley
Caption Management
Kennedy Capital Management
Arrowpoint Asset Management
Susquehanna International
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences